Abstract
Background: Polycystic ovary syndrome (PCOS) is a chronic, heterogeneous and prevalent endocrine-metabolic condition. Objectives: This study aims to synthesize the available evidence on the comparison of lipid accumulation product (LAP) and visceral adiposity index (VAI) in women with and without PCOS. Design: Systematic review and meta-analysis. Data sources and methods: A systematic search was executed across five electronic databases. Continuous variables were assessed using the standardized mean difference (SMD) and its 95% confidence interval (CI). Results: A total of 46 studies were included (n = 12,442). PCOS patients have higher values of LAP (n = 10,658; SMD: 0.65; 95% CI: 0.47–0.83, p < 0.05; I2 = 93.65%) and VAI (n = 7930; SMD: 0.53; 95% CI: 0.21–0.85; p < 0.05; I2 = 97.24%) compared to those without the syndrome. Conclusion: Women with PCOS show significantly higher VAI and LAP values than those without this syndrome.
| Original language | English |
|---|---|
| Journal | Therapeutic Advances in Endocrinology and Metabolism |
| Volume | 16 |
| DOIs | |
| State | Published - 1 Jan 2025 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- adiposity
- lipid accumulation product
- meta-analysis
- polycystic ovary syndrome
- systematic review
- visceral adiposity index
Fingerprint
Dive into the research topics of 'Lipid accumulation product and visceral adiposity index in women with and without polycystic ovary syndrome: a systematic review and meta-analysis'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver